GlaxoSmithKline reported 24.28B in Current Liabilities for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Liabilities Change
Abbvie ABBV:US $ 32521M 2673M
Alcon AG ALC:SW 2.25B 225M
Amgen AMGN:US $ 12886M 702M
Artemis Alpha ATS:LN 5.35M 469K
AstraZeneca AZN:LN 22740M 146M
Bayer BAYN:GR € 31019M 1616M
Biogen BIIB:US $ 3946.6M 351.6M
Bristol Myers Squibb BMY:US $ 22821M 953M
Eli Lilly And LLY:US $ 13386M 1666.7M
Fresenius FRE:GR € 14138M 924M
Fresenius Medical Care FME:GR € 6377.45M 880.18M
Galapagos GLPG:NA € 562.9M 3.58M
Genmab GEN:DC DK 1339M 229M
Gilead Sciences GILD:US $ 8558M 3052M
GlaxoSmithKline GSK:LN 24278M 608M
Glaxosmithkline GSK:US $ 24278M 608M
GRIFOLS GRF:SM € 1921.48M 360.62M
H. Lundbeck A/S LUN:DC 7.83B 988M
Hikma Pharmaceutical HIK:LN 1.02B 56M
Lonza Group LONN:SW 2.37B 739M
Merck MRK:GR € 10207M 225M
Merk MRK:US $ 22316M 1556M
Novartis NOVN:VX SF 29807M 401M
Orion ORNBV:FH € 435.8M 226.6M
Pfizer PFE:US $ 39268M 3403M
Recordati REC:IM € 725.02M 98.6M
Regeneron Pharmaceuticals REGN:US $ 3007.6M 924.9M